Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Artificial intelligence enabled electrospinning approach to fight pulmonary cancer

Project description

Targeting lung cancer relapse with nanotech innovation

Lung cancer remains the leading cause of cancer death worldwide, with surgery often involving high rates of complications and repeated recurrences along resection margins. Supported by the Marie Skłodowska-Curie Actions programme, the RESPIRE project helps a pioneering scientist design a biodegradable nanofibrous patch that delivers chemotherapy directly into lung tissue. The patch, using the technologies of electrospinning and electrospray, will mimic the mechanical behaviour of the lung and release drugs in a controlled fashion. Following instruction in MIT’s AI-facilitated materials design and UTRGV's drug-release modelling, the fellow will return to UNIPI for biological verification. With nanotechnology, medicine, and engineering, RESPIRE hopes to reduce the relapse of lung cancer and accelerate the production of targeted, implantable treatments.

Objective

Pulmonary cancer is the leading cause of cancer deaths worldwide. Surgery is associated with high morbidity and operative mortality. One of the main causes of the poor survival rate is cancer relapse at the surgical resection margins. Thus, developing a strategy to minimize the local recurrence rate of lung cancer efficiently is greatly needed. Nanotechnology-assisted approaches, such as nanoparticles (NPs) and nanofibers (NFs) obtained via electrospinning could enable novel strategies to fabricate better performing implantable devices, including localized drug delivery systems. Many working parameters affect the final outcomes in electrospinning and different fibrous architectures can be generated, much is still to be understood to precisely control, and ultimately predict the mechanical, physico-chemical, and bioactive properties of the resulting meshes, which are essential in pulmonary tissues. The Postdoctoral Fellowship Researcher (PFR) has studied biodegradable fibers as drug delivery systems in her Ph.D. and Post Doc and herein aims to develop a biodegradable nanofibrous patch based on elastin (i.e. the native component of the pulmonary tissues) containing chemotherapeutics via electrospinning/electrospray. To achieve this ambitious goal, the PFR needs to learn multiscale materials design and artificial intelligence to precisely match the mechanical properties of lung tissue, which will be addressed during the outgoing phase at USI. The PFR will also investigate the encapsulation of chemotherapy and immunotherapy agents into electrosprayed NPs at UNIPI and CNR-IPCF (i.e. secondment), model drug-release mechanisms at USI, and analyze drug-release effectiveness using an in vitro model at CNR-IPCF, with the results subsequently used to support the biological assessment during the returning phase at UNIPI. The multidisciplinary approach (engineering, biology, materials and medical sciences), will accelerate the development of innovative clinically oriented prototypes and will contribute to the ER’s scientific and personal.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-GF - HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

UNIVERSITA DI PISA
Net EU contribution
€ 437 351,34
Address
LUNGARNO PACINOTTI 43/44
56126 Pisa
Italy
Region
Centro (IT) Toscana Pisa
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (5)